Video
Dr. Desai on emergence of bladder-sparing surgery in MIBC treatment paradigm
Author(s):
“Your best bladder is the one you were born with,” says Neil Desai, MD.
Video Player is loading.
Neil Desai, MD, associate professor of Radiation Oncology at UT Southwestern Medical Center, discusses how bladder-preservation surgery has emerged as an alternative to radical cystectomy in the treatment paradigm for patients with muscle-invasive bladder cancer of urothelial origin.
Related Videos
Félix Guerrero-Ramos, MD, on TAR-200 in papillary disease-only NMIBC
Joshua J. Meeks, MD, PhD, discusses NIAGARA data for patient undergoing cystectomy
Joseph Jacob, MD, on the durability of TAR-200 in NMIBC
Study data point to gender disparities in oncology research citations
Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBC
Suzanne B. Merrill, MD, FACS, discusses rBCG and the NMIBC landscape
Expert describes implications of neoadjuvant durvalumab approval in MIBC
Sima Porten, MD, on gene-environment interactions in bladder cancer development
How rBCG EAP could open up access for Anktiva in bladder cancer
Betty Wang, MD, recaps 3 key urologic cancer studies from EAU 2025
Related Content
